Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (201-210 of 350) with videos related to

Pageof 35
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1986
Altered expression of G1-specific genes in human malignant myeloid cellsB Calabretta, D Venturelli, L Kaczmarek, et al.
Leukemia|January 22, 1998
Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemiaM Wilhelm, C Bueso-Ramos, S O'Brien, et al.
Blood|October 1, 1987
Therapy of chronic myelogenous leukemia with recombinant interferon-gammaR Kurzrock, M Talpaz, H Kantarjian, et al.
The New England Journal of Medicine|April 24, 1986
Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemiaM Talpaz, H M Kantarjian, K McCredie, et al.
Cancer|January 29, 2000
Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapyK Kaban, H Kantarjian, M Talpaz, et al.
Neurology|May 1, 1995
Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemiaM A Pavol, C A Meyers, J L Rexer, et al.
Blood|September 15, 1991
Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activityZ Estrov, R Kurzrock, M Wetzler, et al.
Leukemia|May 1, 1994
Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alphaA Ferrajoli, M Talpaz, T F Zipf, et al.
Cancer Research|September 1, 1986
In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetaseM G Rosenblum, B L Maxwell, M Talpaz, et al.
Blood|July 1, 1987
Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemiaR Kurzrock, W S Kloetzer, M Talpaz, et al.
Pageof 35

Showing results (201-210 of 350) with videos related to

Sort By:
Pageof 35
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1986
Altered expression of G1-specific genes in human malignant myeloid cellsB Calabretta, D Venturelli, L Kaczmarek, et al.
Leukemia|January 22, 1998
Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemiaM Wilhelm, C Bueso-Ramos, S O'Brien, et al.
Blood|October 1, 1987
Therapy of chronic myelogenous leukemia with recombinant interferon-gammaR Kurzrock, M Talpaz, H Kantarjian, et al.
The New England Journal of Medicine|April 24, 1986
Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemiaM Talpaz, H M Kantarjian, K McCredie, et al.
Cancer|January 29, 2000
Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapyK Kaban, H Kantarjian, M Talpaz, et al.
Neurology|May 1, 1995
Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemiaM A Pavol, C A Meyers, J L Rexer, et al.
Blood|September 15, 1991
Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activityZ Estrov, R Kurzrock, M Wetzler, et al.
Leukemia|May 1, 1994
Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alphaA Ferrajoli, M Talpaz, T F Zipf, et al.
Cancer Research|September 1, 1986
In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetaseM G Rosenblum, B L Maxwell, M Talpaz, et al.
Blood|July 1, 1987
Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemiaR Kurzrock, W S Kloetzer, M Talpaz, et al.
Pageof 35